Two companies are developing a new model for a cloud-based platform that makes possible automated collaborative research with artificial intelligence in synthetic biology. . . . → Read More: Platform to Integrate Robotics, Synthetic Biology, A.I.
|
|||||
|
|
A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies  One comment - (Comments are closed)  Finance, Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, licensing, life sciences, patent, pharmaceuticals, venture capital A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells Comments are closed Intellectual property, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, genomics, grant, licensing, life sciences, NIH, NSF, patent, pharmaceuticals, university MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies Comments are closed Intellectual property biomedical, biotechnology, cancer, genomics, Israel, licensing, life sciences, mathematics, pharmaceuticals, physical sciences A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage. . . . → Read More: RNA Treatment Tested for West Nile Virus Comments are closed New products biomedical, biotechnology, genomics, life sciences, pharmaceuticals, preclinical, university A new initiative is seeking participants from the worldwide research community to develop a multi-dimensional online model of the beta cell that produces insulin, found in the pancreas. . . . → Read More: Crowdsourced Project Building Whole Beta Cell Model Comments are closed Joint ventures/collaborations, New products biomedical, engineering, genomics, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, software, university A bioengineering lab at Harvard University designed a refinement for genome editing to identify and remove small genetic mutations that can lead to diseases or organisms resistant to current drugs. . . . → Read More: Crispr Enhanced to Find, Edit Tiny Mutations Comments are closed New products biomedical, biotechnology, engineering, genomics, life sciences, medical device, patent, pharmaceuticals, university Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests One comment - (Comments are closed) Regulations biomedical, cancer, FDA, genomics, life sciences, medical device Academic scientists studying synthetic biology with help from professional brewers used genome editing to engineer yeast that produces beer with the taste of hops, but without adding hops. . . . → Read More: Genome Editing Yields Quality Beer Without Hops 2 comments - (Comments are closed) New products agriculture, biotechnology, engineering, entrepreneurs, genomics, grant, life sciences, manufacturing, NSF, physical sciences, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
